Abstract
Failure of current therapies to eliminate tumors is, in part, due to inadequate infiltration of immune cells. The importance of endothelial cells for the induction of immune responses is now being recognized. However, tumor endothelial cells (TECs) are dysfunctional, leading to decreased tumor immunity. Because TEC metabolism contributes to the abnormal vascular phenotype, interest is growing in the tumor vasculature as a target to improve immune responses. Recent insights into the relationship between TEC metabolism and immunity suggest that normalization of the tumor vasculature through metabolic reprogramming could be an important tool to improve immune-based anti-cancer therapies.
Original language | English |
---|---|
Article number | 100376 |
Journal | Current Opinion in Systems Biology |
Volume | 28 |
ISSN | 2452-3100 |
DOIs | |
Publication status | Published - Dec 2021 |
Keywords
- Activation
- Cancer
- Endothelial cells
- Immunoregulation
- Inflammation
- Metabolism